NO20071319L - Fremgangsmate for fremstilling av isotiazolderivater. - Google Patents

Fremgangsmate for fremstilling av isotiazolderivater.

Info

Publication number
NO20071319L
NO20071319L NO20071319A NO20071319A NO20071319L NO 20071319 L NO20071319 L NO 20071319L NO 20071319 A NO20071319 A NO 20071319A NO 20071319 A NO20071319 A NO 20071319A NO 20071319 L NO20071319 L NO 20071319L
Authority
NO
Norway
Prior art keywords
preparation
isothiazole derivatives
isothiazole
derivatives
prodrugs
Prior art date
Application number
NO20071319A
Other languages
English (en)
Norwegian (no)
Inventor
David B Damon
Brian P Jones
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20071319L publication Critical patent/NO20071319L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20071319A 2004-08-26 2007-03-09 Fremgangsmate for fremstilling av isotiazolderivater. NO20071319L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60454204P 2004-08-26 2004-08-26
PCT/US2005/027398 WO2006026034A2 (en) 2004-08-26 2005-08-02 Processes for the preparation of isothiazole derivatives

Publications (1)

Publication Number Publication Date
NO20071319L true NO20071319L (no) 2007-05-29

Family

ID=36000502

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071319A NO20071319L (no) 2004-08-26 2007-03-09 Fremgangsmate for fremstilling av isotiazolderivater.

Country Status (21)

Country Link
US (2) US8884025B2 (enExample)
EP (1) EP1784183B1 (enExample)
JP (2) JP5100390B2 (enExample)
KR (1) KR100893977B1 (enExample)
CN (1) CN101043888B (enExample)
AR (1) AR050613A1 (enExample)
AT (1) ATE542533T1 (enExample)
AU (1) AU2005280451B2 (enExample)
BR (1) BRPI0514667A (enExample)
CA (1) CA2578023C (enExample)
DK (1) DK1784183T3 (enExample)
ES (1) ES2378994T3 (enExample)
IL (1) IL181063A0 (enExample)
MX (1) MX2007002246A (enExample)
NO (1) NO20071319L (enExample)
PL (1) PL1784183T3 (enExample)
PT (1) PT1784183E (enExample)
RU (1) RU2349588C2 (enExample)
TW (1) TWI361688B (enExample)
WO (1) WO2006026034A2 (enExample)
ZA (1) ZA200701016B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007002246A (es) 2004-08-26 2007-04-20 Pfizer Prod Inc Procedimientos para la preparacion de derivados de isotiazol.
ES2623652T3 (es) 2011-12-28 2017-07-11 Allergan, Inc. Derivados de 3-fenil-5-ureidoisotiazol-4-carboximida y 3-amino-5-fenilisotiazol como inhibidores de cinasa
CN103833665B (zh) * 2014-02-24 2015-09-23 杰达维（上海）医药科技发展有限公司 一种新的合成异噻唑的方法
US9353093B2 (en) 2014-10-07 2016-05-31 Allergan, Inc. Indole-1-carboxamides as kinase inhibitors
US9403803B2 (en) 2014-10-08 2016-08-02 Allergan, Inc. Indole-3-carboxamides as kinase inhibitors
US9359336B2 (en) 2014-10-09 2016-06-07 Allergan, Inc. Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
US9371314B2 (en) 2014-10-09 2016-06-21 Allergan, Inc. Pyridyl benzothiophenes as kinase inhibitors
KR20250121146A (ko) * 2022-12-28 2025-08-11 비양 테라퓨틱스 컴퍼니 리미티드 단백질 티로신 키나제 억제제 및 이의 의약적 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2408234A1 (de) * 1974-02-21 1975-09-04 Celamerck Gmbh & Co Kg Isothiazolylharnstoffe
US4059433A (en) * 1976-06-18 1977-11-22 Fmc Corporation 3-Alkoxyisothiazole derivatives as herbicides
IL72093A0 (en) * 1983-06-20 1984-10-31 Lilly Co Eli N'-substituted(3-alkyl-5-isothiazolyl)urea derivatives
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
HN2000000051A (es) * 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
GB0010188D0 (en) * 2000-04-26 2000-06-14 Ferring Bv Inhibitors of dipeptidyl peptidase IV
JP4511352B2 (ja) * 2002-07-25 2010-07-28 ファイザー・インク 抗癌薬として有用なイソチアゾール誘導体
US20060035954A1 (en) * 2004-08-11 2006-02-16 Sharma Padam N Ammonolysis process for the preparation of intermediates for DPP IV inhibitors
MX2007002246A (es) 2004-08-26 2007-04-20 Pfizer Prod Inc Procedimientos para la preparacion de derivados de isotiazol.

Also Published As

Publication number Publication date
AU2005280451A1 (en) 2006-03-09
CA2578023C (en) 2012-05-15
US20150065726A1 (en) 2015-03-05
PT1784183E (pt) 2012-03-09
BRPI0514667A (pt) 2008-06-17
JP5100390B2 (ja) 2012-12-19
ZA200701016B (en) 2008-05-28
EP1784183A2 (en) 2007-05-16
AR050613A1 (es) 2006-11-08
RU2007106847A (ru) 2008-08-27
JP5498524B2 (ja) 2014-05-21
CN101043888B (zh) 2010-08-11
WO2006026034A3 (en) 2006-06-29
MX2007002246A (es) 2007-04-20
RU2349588C2 (ru) 2009-03-20
CN101043888A (zh) 2007-09-26
IL181063A0 (en) 2007-07-04
AU2005280451B2 (en) 2009-02-05
PL1784183T3 (pl) 2012-07-31
KR100893977B1 (ko) 2009-04-20
US20090023924A1 (en) 2009-01-22
TWI361688B (en) 2012-04-11
DK1784183T3 (da) 2012-04-02
US9371298B2 (en) 2016-06-21
KR20070070158A (ko) 2007-07-03
HK1111359A1 (en) 2008-08-08
JP2008510841A (ja) 2008-04-10
EP1784183A4 (en) 2009-12-09
ES2378994T3 (es) 2012-04-19
CA2578023A1 (en) 2006-03-09
US8884025B2 (en) 2014-11-11
WO2006026034A2 (en) 2006-03-09
JP2012153705A (ja) 2012-08-16
TW200621241A (en) 2006-07-01
ATE542533T1 (de) 2012-02-15
EP1784183B1 (en) 2012-01-25

Similar Documents

Publication Publication Date Title
ZA200708159B (en) 1-Acetic acid-indole derivatives with PDG2 antagonist activity
NO20071319L (no) Fremgangsmate for fremstilling av isotiazolderivater.
NO20076066L (no) Oksadiazolderivater som DGAT-inhibitorer
NO20051303L (no) Nye benzoimidazolderivater nyttige som antiproliferative midler
NO20083434L (no) Benzamid- og heteroarenderivater
NO20054852L (no) GFAT inhibitorer
TW200833675A (en) Nicotinamide derivatives
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
MX2009012418A (es) Derivados de quinazolin-oxima como inhibidores de hsp90.
TW200728307A (en) Novel spirochromanone derivatives
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
NO20076695L (no) Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
ATE512961T1 (de) Amorphes nebivolol hydrochlorid und seine herstellung
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
NO20075409L (no) Substituerte aminoalkyl- og amidoalkyl-benzopyranderivater
MX2007007105A (es) Procedimiento para la preparacion de un derivado de 2-piridiletilcarboxamida.
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
NO20064344L (no) Caspaseinhibitorer og anvendelser derav
NO20065902L (no) 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler
NO20065873L (no) 3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjoner
MX2012002529A (es) Agente terapeutico para trastornos de ansiedad.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application